Last reviewed · How we verify
NCT07505498: Scope-PRO
Screening for Supportive Care Needs of Oncological Patients and Professionals - Evaluation of a Short PRO-question Set
trial in Patient Related Outcome Measures in 900 participants. Currently enrolling.
1 January 2027
Quick facts
| Lead sponsor | University Medical Center Goettingen |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 900 |
| Start date | 1 December 2025 |
| Primary completion | 1 January 2027 |
| Estimated completion | 31 December 2027 |
| Sites | 1 location across Germany |
Conditions studied
- Patient Related Outcome Measures — all drugs for Patient Related Outcome Measures →
- Supportive Care — all drugs for Supportive Care →
- Patient Reported Outcome (PRO) — all drugs for Patient Reported Outcome (PRO) →
Sponsor
University Medical Center Goettingen
Who can join
18 and older, any sex, with Patient Related Outcome Measures or Supportive Care. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The systematic recording of patient-reported symptoms and health-related quality of life (patient-reported outcomes, PROs) is a central component of oncological care. Currently, however, screening for support needs in German hospitals is inconsistent and uses different assessment tools, leading to heterogeneity, redundant surveys, and limited comparability of results. This complicates standardized, patient-centered, and cross-sector care, as well as the early identification of therapy-associated side effects and support needs. The aim of the study is to investigate the acceptance and relevance of the core set of questions from the perspective of both cancer patients and professional healthcare providers. Cancer patient acceptance will be measured by the proportion of fully completed questionnaires, while cancer patient relevance will be assessed using a feedback form. The professional perspective will be gathered through guided feedback in quality circles conducted regularly in accordance with internal standards
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07505498
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Medical Center Goettingen trials
Trials by the same sponsor.
- NCT07008677 — Oral Health Awareness and Status Among Professional Musicians in German Orchestras · completed
- NCT07529041 — Real-time Acoustic Biofeedback for Enhancing Fixation Stability: A Proof-of-concept Study to Improve Ophthalmic Imaging · NA · enrolling by invitation
- NCT06921863 — This Study Aims to Quantify Decisional Regret as Well as Quality of Life in Patients With Low- to High-risk Cancer and H · not yet recruiting
- NCT07476365 — A Multi-omic Approach to the Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease (CMT1A) · recruiting
- NCT07056738 — Prospective Exploratory Cohort Study on Ganglion Cell Degeneration in Retinitis Pigmentosa Patients · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07505498 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Medical Center Goettingen
- Last refreshed: 1 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07505498.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing